Today, Martin J. Blaser of New York University's School of Medicine spoke to a standing-room-only crowd on "The Dark Side of Antibiotics." Prof. Blaser provided an overview of what we've learned about changes to the human microbiome over the past 70+ years. His talk focused on obesity, diabetes, asthma and other harms that appear to be linked to the aggressive use of antibiotics. Prof.
Every year, the Consortium sponsors leading national programs, undertakes cross-disciplinary research and provides grants to support scholarship on the societal implications of the life sciences.
Genetically modified organisms (GMOs) have the potential to help prevent the spread of diseases and increase both crop yields and nutritional value, but according to an article in Science Alert, "There's a big problem. . . .
How can we harness the big social, technological, and infrastructural changes arising in cities for the greatest good?
Two recently published articles, one written by Consortium Chair Susan M. Wolf and the other by LawSeqSM Working Group member Barbara J. Evans, grapple with important issues in genetic research ethics.
Jeffrey Kahn, Director of the Berman Institute of Bioethics at Johns Hopkins University, joined Minnesota Public Radio host Kerri Miller today to discuss innovations in gene editing and the consequences that must be considered as it moves into clinical application. New tools like CRISPR are much more targeted than past gene therapies; m
A brain stimulation device just approved by the US Food and Drug Administration (FDA) was developed as part of a multi-site clinical study led by University of Minnesota medical researchers and partly funded by the MnDRIVE program. According to Twin Cities Business, neurology department chair Dr.
An article in MIT Technology Review notes, "In just the past few years, advances in [the gene-editing technology] CRISPR have been happening at a breakneck speed — and companies have sprung up to commercialize the technology. Now, patients in Europe and the U.S.
The National Insitutes of Health (NIH) has ended "a moratorium imposed three years ago on funding research that alters germs to make them more lethal," according to the New York Times. The goal of such research is to better understand the mechanisms that drive pathogens to mutate and become deadly; the new guideline requires the germ pose a "serious health threat" and that the research be done in a highly secure lab.
A state-of-the-art genetic analysis tool has been deployed to Willmar, Minnesota, the heart of the state's burgeoning turkey business. According to an article in Agweek, beginning in 2017 the Food and Drug Administration (FDA) is implementing new restrictions that change how livestock producers use antibiotics in feed to promote growth.